| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.007 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.1 | 0.007 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.008 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.008 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.008 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | 0.086 | 0.008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.081 | 0.008 |